Our mission drives us – More life for people with cancer.
That’s why our work doesn’t stop when the research is done, or the discovery made. The burden of cancer is vast – on patients, their loved ones, and their healthcare providers – but so are our aspirations to redefine how cancer is treated.
More hope. More moments. More life.
Letter to Our Shareholders
“Our late-stage oncology pipeline has the potential to have a profound impact on patients’ lives. We are driven to develop and deliver more effective and safer treatment options for some of the world’s most difficult-to-treat blood cancers.”
Jean-Paul Kress, M.D., Chief Executive OfficerRead More